SenesTech Ownership

SNES Stock  USD 2.38  0.10  4.39%   
About 98.1 % of SenesTech outstanding shares are held by general public with 0.01 (%) owned by insiders and only 1.89 % by institutional holders.
Some institutional investors establish a significant position in stocks such as SenesTech in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of SenesTech, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.
Dividend Yield is likely to gain to 0.01 in 2024, whereas Dividends Paid is likely to drop slightly above 14.5 K in 2024. Common Stock Shares Outstanding is likely to drop to about 34.1 K in 2024. Net Loss is likely to drop to about (11.7 M) in 2024.
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
  
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in SenesTech. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.
For more information on how to buy SenesTech Stock please use our How to Invest in SenesTech guide.

SenesTech Stock Ownership Analysis

The company has price-to-book ratio of 0.65. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. SenesTech recorded earning per share (EPS) of 112.6. The entity last dividend was issued on the 5th of February 2020. The firm had 1:10 split on the 25th of July 2024. SenesTech, Inc. develops a technology for managing animal pest populations through fertility control. The company was incorporated in 2004 and is headquartered in Phoenix, Arizona. Senestech operates under Specialty Chemicals classification in the United States and is traded on NASDAQ Exchange. It employs 26 people. To find out more about SenesTech contact Joel Fruendt at 928 779 4143 or learn more at https://www.senestech.com.
Besides selling stocks to institutional investors, SenesTech also allocates a substantial amount of its earnings to a pull of share-based compensation to be paid out to its employees, managers, executives, and members of the board of directors. Share-Based compensation (also sometimes called Stock-Based Compensation) is a way of paying different SenesTech's stakeholders with equity in the business. It is typically used as a motivation factor for employees to contribute beyond their regular compensation (salary and bonus). It is also used as a tool to align SenesTech's strategic interests with those of the company's shareholders. Shares issued to employees are usually subject to a vesting period before they are earned and sold.

SenesTech Quarterly Liabilities And Stockholders Equity

4.45 Million

SenesTech Insider Trades History

Less than 1% of SenesTech are currently held by insiders. Unlike SenesTech's institutional investors, corporate insiders most likely have a limit on the maximum percentage of share ownership. This is done to align insiders' influence against SenesTech's private investors even though both sides will benefit from rising prices or experience loss when the share price declines. The good rule to have in mind is that the maximum share ownership percentage of the corporate insiders should not surpass 25%. View all of SenesTech's insider trades
 
Yuan Drop
 
Covid

SenesTech Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as SenesTech is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading SenesTech backward and forwards among themselves. SenesTech's institutional investor refers to the entity that pools money to purchase SenesTech's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares
Susquehanna International Group, Llp2024-06-30
0.0
Wells Fargo & Co2024-06-30
0.0
Sabby Management Llc2024-06-30
0.0
Tower Research Capital Llc2024-06-30
0.0
Mcadam, Llc2024-09-30
0.0
Old Point Trust & Financial Services N A2024-06-30
0.0
Fidelity Management And Research Company2024-06-30
0.0
Virtu Financial Llc2024-06-30
0.0
Hrt Financial Llc2024-06-30
0.0
Note, although SenesTech's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

SenesTech Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific SenesTech insiders, such as employees or executives, is commonly permitted as long as it does not rely on SenesTech's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases SenesTech insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

SenesTech Outstanding Bonds

SenesTech issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. SenesTech uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most SenesTech bonds can be classified according to their maturity, which is the date when SenesTech has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

SenesTech Corporate Filings

13A
14th of November 2024
An amended filing to the original Schedule 13G
ViewVerify
8K
12th of November 2024
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify
4th of October 2024
Other Reports
ViewVerify
23rd of September 2024
Other Reports
ViewVerify

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for SenesTech Stock Analysis

When running SenesTech's price analysis, check to measure SenesTech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy SenesTech is operating at the current time. Most of SenesTech's value examination focuses on studying past and present price action to predict the probability of SenesTech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move SenesTech's price. Additionally, you may evaluate how the addition of SenesTech to your portfolios can decrease your overall portfolio volatility.